Skip to content
TrustList
AI Fund logo
Investor

AI Fund

Venture studio and investor building companies that apply artificial intelligence across many industries

AI Fund cover

About AI Fund

AI Fund is a venture studio and investor that works with founders applying artificial intelligence and machine learning to hard problems. Its site describes AI as a new kind of general-purpose utility.

What AI Fund offers

  • Company building — a venture studio route for entrepreneurs to start companies.
  • Investment — backing for founders using artificial intelligence.
  • Community — an AI Link Community and a Build with Us programme.

Who it works with

The founders it partners with work in fields ranging from manufacturing and mental health to maritime shipping, education and training. The site also carries articles on the AI talent gap, on raising money in a downturn, and on Warren Packard joining as Operating Partner.

Key facts

  • Focus: Artificial intelligence and machine learning
  • Model: Venture studio and investor
  • Leadership: Warren Packard, Operating Partner

Profile written by TrustList from the business's own published information, Oct 2026.

Categories & features

Rankings

As of 2026-10-05. Organic ranks only; sponsored placements are never ranks.

Ask TrustList to introduce you to AI Fund

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA — Google Privacy Policy and Terms apply.

Reviews

Write the first review of AI Fund

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about AI Fund.

AI Fund alternatives

Similar listings buyers compare against this one.

Venture capital firm investing in climate tech, biotech, aerospace and next-generation computing companies

Corporate venture arm of Merck investing globally in healthcare, life sciences, electronics and sustainability

Investor in entrepreneurs commercialising breakthroughs in genomics, synthetic biology, therapeutics, materials and diagnostics